8 Common Psychedelic Mistakes
By Psychedelics Today
Gain crucial insights into avoiding common pitfalls in psychedelic experiences with this 1-hour, self-paced webinar. Ideal for those seeking safe navigation.
This article examines the history of psychedelic medicine being used in conversion therapy and the ongoing harms of heteronormative assumptions in psychedelic science. It outlines the need for LGBTQ-affirmative psychedelic therapy and identifies key areas for change in clinical practice and training.
Chacruna
English
15 years
This piece reviews documented cases in which psychedelic medicines were used in anti-therapeutic attempts to change LGBTQ people’s sexual orientation or gender identity. It places these practices in historical context and notes that such approaches are now considered unethical and harmful. The article is framed as a brief educational overview for readers in the psychedelic field, including therapists, researchers, and trainees. It focuses on the history of harm, current shortcomings in the field, and practical considerations for moving toward LGBTQ-affirmative psychedelic therapy. The source text does not describe a formal course structure, module sequence, or assessment format. It presents the topic as a short article rather than a credentialed training program.
Therapists, researchers, and trainees in the psychedelic field
Nonprofit platform focused on psychedelic education, cultural justice, and Indigenous reciprocity with programming at the intersection of ethics, policy, and community knowledge.
By Psychedelics Today
Gain crucial insights into avoiding common pitfalls in psychedelic experiences with this 1-hour, self-paced webinar. Ideal for those seeking safe navigation.
By Atma Journey
This course is made for mental health professionals (in Canada) who want to learn how to work with psychedelics. The course staff includes Mark Haden Anthony Bossis, and many more.
By Double Blind
This article examines how ketamine clinics may serve as a model for future legal psychedelic therapy, especially for MDMA and psilocybin. It compares clinic models, regulation, and the role of psychotherapy in treatment delivery.